William D. Schmitz

Person

Cheshire, CT, US

People

Patents Grantslast 30 patents

Information Patent Grant
5H-pyrido[3,2-B]indole compounds as anticancer agents
- Patent number 10,174,024
- Issue date Jan 8, 2019
- Bristol-Myers Squibb Company
- Wen-Ching Han
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Tricyclic compounds as anticancer agents
- Patent number 9,751,879
- Issue date Sep 5, 2017
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Tricyclic compounds as anticancer agents
- Patent number 9,725,449
- Issue date Aug 8, 2017
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Inhibitors of PDE10
- Patent number 8,975,276
- Issue date Mar 10, 2015
- Bristol-Myers Squibb Company
- William D. Schmitz
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Substituted heterocyclic ethers and their use in CNS disorders
- Patent number 7,632,861
- Issue date Dec 15, 2009
- Bristol-Myers Squibb Company
- Joanne J. Bronson
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Phosphate prodrugs of fluoroxindoles
- Patent number 6,930,100
- Issue date Aug 16, 2005
- Bristol-Myers Squibb Company
- Kevin W. Gillman
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
5H-PYRIDO[3,2-B]INDOLE COMPOUNDS AS ANTICANCER AGENTS
- Publication number 20180093983
- Publication date Apr 5, 2018
- Bristol-Mayers Squibb Company
- Wen-Ching HAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
- Publication number 20160333013
- Publication date Nov 17, 2016
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
- Publication number 20160326173
- Publication date Nov 10, 2016
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
- Publication number 20160318928
- Publication date Nov 3, 2016
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS
- Publication number 20160176864
- Publication date Jun 23, 2016
- Bristol-Myers Squibb Company
- Derek J. Norris
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Inhibitors of PDE10
- Publication number 20130165447
- Publication date Jun 27, 2013
- Bristol -Myers Squibb Company
- William D. Schmitz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted Heterocyclic Ethers and Their Use in CNS Disorders
- Publication number 20090124613
- Publication date May 14, 2009
- Bristol -Myers Squibb Company
- Joanne J. Bronson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Substituted Heterocyclic Ethers and Their Use in CNS Disorders
- Publication number 20090018163
- Publication date Jan 15, 2009
- Bristol -Myers Squibb Company
- William D. Schmitz
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Phosphate prodrugs of fluorooxindoles
- Publication number 20030195169
- Publication date Oct 16, 2003
- Kevin W. Gillman
- C07 - ORGANIC CHEMISTRY

William D. Schmitz

Person

Patents Grantslast 30 patents

5H-pyrido[3,2-B]indole compounds as anticancer agents

Tricyclic compounds as anticancer agents

Tricyclic compounds as anticancer agents

Inhibitors of PDE10

Substituted heterocyclic ethers and their use in CNS disorders

Phosphate prodrugs of fluoroxindoles

Patents Applicationslast 30 patents

5H-PYRIDO[3,2-B]INDOLE COMPOUNDS AS ANTICANCER AGENTS

TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS

Inhibitors of PDE10

Substituted Heterocyclic Ethers and Their Use in CNS Disorders

Substituted Heterocyclic Ethers and Their Use in CNS Disorders

Phosphate prodrugs of fluorooxindoles